As COVID demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50%

Becton Dickinson masterminded the pre-fillable syringe, and decades later, it's a technology key to the global COVID-19 vaccine rollout. And with pandemic demand surging, BD is planning to shell out $1.2 billion to expand that very business.